Genetic Testing Panels Market Highly Favorable to the Growth Rate by 2028(Based on end user, the global genetic testing panels market is segmented into: Research Laboratory Academic & Research Institutes Diagnostic Labs Others)
Genetic testing panels are one of the rapidly growing segments in the molecular diagnostics industry and help in delivering personalized medicine. With the help of genetic testing panels, people can learn about inherited mutations. Genetic testing panels were introduced to examine dozens of cancer genes in order to reduce the risk of cancer, as it is considered the leading cause of mortality and morbidity globally. The sensitivity and specificity of the genetic testing panels vary depending on the characteristics of the cancer stage, heterogeneity, etc. Genetic testing panels make it possible to sequence, process and analyze large volumes of genes. Genetic testing panels use next-generation sequencing technology.
Genetic Testing Panels Market: Drivers and Restraints
The growth of the genetic testing panels market is majorly driven by increasing incidence and prevalence of a variety of cancer and genetic diseases. In addition, increasing government investments in research and development activities and awareness about genetic testing panels are also the prime factors projected to impel the growth of the global genetic testing panels market over the forecast period. However, factors such as complex regulatory framework, and scarcity of skilled professionals, among others are the major obstacles in the growth of the genetic testing panels market. Moreover, lack of sufficient information to guide the people in prevention strategies is expected to hamper the growth of the genetic testing panels market.
Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=2820
Genetic Testing Panels Market: Segmentation
The global genetic testing panels market can be segmented on the basis of application, end user, and geography.
Based on application, the global genetic testing panels market is segmented into:
Drug Research & Development
Based on end user, the global genetic testing panels market is segmented into:
Academic & Research Institutes
Genetic Testing Panels Market: Overview
The global market for genetic testing panels market is expected to witness significant growth over the forecast period. Presently, many genetic testing panels for cancer susceptibility are available in the market. Advancements in both research and technology around hereditary cancer have increased the adoption of genetic testing panels. The cost-effectiveness of genetic testing panels and less need of sequential testing also support the growth of the genetic testing panels market. Genetic testing panels are advanced DNA screenings, which identify the specific genes and genetic mutations that can be related to major cancers. Amongst all the end users of the genetic testing panels market, the research laboratory segment is expected to hold significant share in the global genetic testing panels market majorly due to increasing incidence of cancer cases.
Genetic Testing Panels Market: Regional Outlook
Geographically, the global genetic testing panels market is segmented into North America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). The North America genetic testing panels market is expected to hold large share, followed by Europe due to the increasing private and public funding for research and development activities. Moreover, the increasing number of cancer patients and increasing per capita income are also driving the growth of the genetic testing panels market in the region. The genetic testing panels market in Asia-Pacific is estimated to grow at the fast rate during the forecast period owing to the modernization of medical and research facilities. Presence of a large population base including a large base of the geriatric population holds potential promises in the growth of genetic testing panels market. However, regions such as Latin America, and the Middle East and Africa are projected to witness sluggish growth during the forecast period.
Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2820
Genetic Testing Panels Market: Key Players
There are many companies who are offering genetic testing panels for cancer as it is growing very rapidly. Examples of some of the key players operating in the global genetic testing panels market are THE JACKSON LABORATORY, Illumina, Inc., Invitae Corporation, and others. Manufacturers are adopting both organic and inorganic strategies to retain their market share in the global genetic testing panels market.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
Supply & Demand
Competition & Companies Involved
Regional analysis includes:
North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
CIS & Russia
Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Report Analysis@ https://www.factmr.com/report/2820/genetic-testing-panels-market
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
Read Industry News at - http://theguardiantribune.com
This release was published on openPR.
Permanent link to this press release:
You can edit or delete your press release Genetic Testing Panels Market Highly Favorable to the Growth Rate by 2028(Based on end user, the global genetic testing panels market is segmented into: Research Laboratory Academic & Research Institutes Diagnostic Labs Others) here
News-ID: 1665760 • Views: 213
More Releases from Fact.MR
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
Fluid Management Market Expected to Grow Amid Covid-19, Finds Fact.MR
Growing prevalence of chronic disease and an expansion in numbers of geriatric population is leading to an upward facing growth curve for global fluid management market over the period of 2020 to 2025, states Fact.MR. It projects a compound annual growth rate or CAGR of about 5.3% for the market over this period, helping the market push its worth up significantly. It is significant to note here that while number of
Hand Sanitizer Market to Surpass US$ 2.8 Bn, Instant Hand Sanitizer Poised to Ho …
The global hand sanitizer market is set to surpass a value of ~US$ 1.4 Bn in 2020 and is anticipated to cross US$ ~2.8 Bn during the forecast period 2020-2030. The demand for gel-based sanitizer is on the rise as compared to foaming or spray sanitizer. Thus, manufacturers are focusing on developing gel-based sanitizers as they are widely used in multiple end-use industries. With the increased penetration of the online
Medical Marker Bands Market Grows on the back of Their Radiopacity and Cost-effe …
Radiopacity of medical marker bands is giving significant impetus to their demand in the medical marker bands market. The properties of medical marker bands that increases their visibility under fluoroscopes or x-ray during critical procedures is giving an uptick to their sales worldwide. Manufacturers of medical marker bands are also showing a marked preference for cost-effective materials such as polymer and tantalum instead of traditional gold, platinum and palladium. On
More Releases for Genetic
Preimplantation Genetic Diagnosis: Scope & Revenue Outlook
Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the
Preimplantation Genetic Testing Market-Size Report 2022
Preimplantation Genetic Testing Market by type 2017-2022 by new Service spreads across 204 pages profiling 17 companies and supported with 85 tables and 42 figures available at ReportsnReports.com Get sample copy for information professional insights@ http://www.reportsnreports.com/contacts/requestsample.aspx?name=1128201 “Preimplantation Genetic Testing Market projected to grow at a CAGR of 10.0%” The global preimplantation genetic testing market is expected to reach USD 541.8 million by 2022 from USD 336.4million in 2017, at a CAGR
India Genetic Testing Market Analysis
India is witnessing an accelerating shift towards the prevalence of non-communicable diseases, having secured third position in congenital malformations and genetic disorders as the commonest causes of mortality in neonates in cities. The ability to identify these non-communicable diseases at an early stage lies within the genetic screening segment. Genetic screening, however, is still in its infancy and there are many challenges that need to be overcome in order to
RBD Creative partners with Reproductive Genetic Innovations
Acknowledged in D Business' Faces of Detroit in 2015, RBD Creative, a local Plymouth marketing and design studio, is proud to announce a new partnership with Reproductive Genetic Innovations (RGI) of Northbrook, IL. RBD Creative specializes in health and wellness marketing solutions and has several notable clients including: University of Michigan Health System, University of Michigan School of Medicine, Lakes Urgent Care, Evangelical Homes of Michigan, Cryowellness USA, Michigan Reproductive
Preimplantation Genetic Diagnosis - Saving Offsprings From Any Genetic Disorder
The market for preimplantation genetic diagnosis (PGD) in Asia features high fragmentation when it comes to diagnostic service providers. The large number of local players has intensified the competitive rivalry in the region. However, owing to the lack of better alternatives to PGD, costs of these procedures remain high, a major limiting factor for the market, especially in cost-sensitive developing countries in the region. A recent report by TMR suggests that
OGT aids research into molecular genetic disease
Unique CytoSure™ Molecular Testing Arrays provide high throughput CNV detection for multiple disorders on a single chip Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced a new range of CytoSure™ Molecular Testing Arrays and Panels. The new DNA microarrays utilise a unique collection of probes for detecting copy number variations (CNVs) within genes associated with a variety of disorders. Three